JSPR

Jasper Therapeutics, Inc. Common Stock
$0.53 -35.56%

Recent alerts on JSPR

All signals →
SEC filing JSPR Explores Strategic Alternatives, Evaluates Cost-Saving Measures to Preserve Cash, Considers Sale, Licensing, or Wind-Down of Operations
1d ago
News Jasper Reports Wider Loss in Fiscal Q2
14d ago
Short volume Short volume 55% of volume (6.0σ)
109d ago
Scanner Unusual volume (2.8x average)
117d ago
News Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous Urticaria
145d ago
News JASPER LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds Investors a Jasper Investors to Contact the Firm Regarding Class Action Lawsuit
153d ago
News ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
153d ago
News Bragar Eagel & Squire, P.C. Reminds Investors of Jasper, KBR, Spirit Aviation, and Molina to Contact the Firm About their Rights in Filed Class Action Lawsuits
153d ago
News ROSEN, SKILLED INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
153d ago
News ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
153d ago
News ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – JSPR
153d ago
News Deadline Alert: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
153d ago
News JASPER CLASS ACTION: Bragar Eagel & Squire, P.C. Reminds Jasper Stockholders of the November 18th Deadline for Filed Class Action Lawsuit
153d ago
News Deadline Alert: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
153d ago
News JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Jasper Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
153d ago

Get push alerts for JSPR

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS